Risk factors for high level cytomegalovirus viremia in liver transplant recipients and associated outcomes.
Hanna L KleiboekerMargaret R JorgensonGlen E LeversonJohn P RiceChristopher M SaddlerJeannina A SmithDavid Al-AdraPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
HL CMV after liver transplant is uncommon but is associated with a significantly increased risk of graft loss that is not present in those patients who develop LL CMV or do not develop CMV viremia. Given these negative graft effects, CMV stewardship interventions targeting recipients of CMV seropositive allografts are warranted. Future larger scale studies evaluating the potential role of other factors in risk stratification are needed.